In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, ProPhase Labs Inc’s stock clocked out at $0.30, down -0.33% from its previous closing price of $0.30. In other words, the price has decreased by -$0.33 from its previous closing price. On the day, 1.07 million shares were traded.
Ratios:
To gain a deeper understanding of PRPH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.33 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 20, 2021, initiated with a Buy rating and assigned the stock a target price of $12.
On January 20, 2021, Dawson James started tracking the stock assigning a Buy rating and target price of $25.Dawson James initiated its Buy rating on January 20, 2021, with a $25 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.00 while its Price-to-Book (P/B) ratio in mrq is 0.15.
Stock Price History:
Over the past 52 weeks, PRPH has reached a high of $5.45, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -15.29%, while the 200-Day Moving Average is calculated to be -75.96%.
Shares Statistics:
A total of 41.88M shares are outstanding, with a floating share count of 36.97M. Insiders hold about 11.73% of the company’s shares, while institutions hold 5.92% stake in the company.
